Company Overview

Company name: TerrAscend (CNQ: TER)
Also known as:
Description: Operator of a vertically-integrated Canadian cannabis company intended to create and deliver quality products and services that meet the evolving needs of the cannabis market. The company’s focus lies in providing support to patients through its wholly-owned subsidiaries which offer medical cannabis under the Access to Cannabis for Medical Purposes Regulations, clinical support program and education platform led by health care professionals and a drug preparation premises for non-cannabis formulations.
Year founded: 2017
Parent company:
Industry: Healthcare | Group: Other Healthcare | Code:
City: Mississauga
State: Ontario
Country: Canada
Region: Americas

Financial Highlights

Start up capital raised (USD Million): 53.51
Business status: Profitable
Ownership: Publicly Held
Exchange: CNQ
Ticker: TER
Revenue (USD Million): 1.39
Gross profit (USD Million):
Net income (USD Million) -8.85
Enterprise value: 455.74
Earnings before interest, tax, depreciation and amortization (EBITDA): -9.36
Fiscal period: TTM 3Q2018
Financing Status: The company (CNQ: TER) received $52.5 million of developmental capital from JW Asset Management and Canopy Growth on December 11, 2017 through a private placement. The company will also join Canopy Growth’s CraftGrow program, whereby the company will provide a select quantity of premium cannabis to be sold through Canopy Growth’s distribution network. The Company intends to use the proceeds from the proposed investment for expansion of its existing facility, the pursuit of a variety of strategic pharmaceutical assets, and for working capital and general corporate purposes.
Number of active investors:
Profile last updated: 23-Oct-2018
Last known valuation: 107.14
Last known valuation date: 11-Dec-2017